Future development of walking speed limitations is associated with cardiovascular risk factors (CRF) in elderly adults, according to a recent study, which also finds that the relationship is independent of cognitive function.
The long-term mortality benefit conferred by mechanical over biologic prosthesis in valve replacement appears to be age- and location-dependent, according to findings of a US-based retrospective study.
Reducing low-density lipoprotein cholesterol (LDL-C) with statin may confer short- and long-term benefits for the primary prevention of cardiovascular disease (CVD) in patients with LDL-C ≥190 mg/dL, according to posthoc data from WOSCOPS (West of Scotland Coronary Prevention Study).
An elevation in white blood cell counts appears to independently predict the risk of new-onset peripheral arterial disease (PAD), according to a Chinese cohort study, which suggests that systemic inflammation plays an important role in the development of PAD.
A blood pressure (BP) reading of 130/80 mm Hg or higher is the ‘new high’ in the latest AHA/ACC* hypertension guidelines, a threshold that is tighter than the JNC 7** cutpoint of 140/90 mm Hg for stage 1 hypertension in the general population. The change will mean more patients being labelled with hypertension.
Long-term use of benzodiazepines is independently associated with lower diastolic and systolic blood pressure in ambulatory blood pressure monitoring (ABPM) among older but not younger patients, a study has found.
Frank’s sign, a diagonal crease in the earlobe that starts from the tragus to the edge of the auricle in an angle of 45° in varying depths, is a risk factor for ischaemic cerebrovascular events, a recent study has found. Its prevalence is high among patients with classical cardiovascular (CV) predictors.
Even small risk reductions achieved with improved air quality afford health benefits similar to that gained with smoking and systolic hypertension control, according to a study in an urban China population.
At a recent lunch symposium during the 14th Annual Scientific Meeting of the Malaysian Society of Hypertension, Dr Chow Yok Wai spoke on the importance of patient adherence in the management of hypertension, highlighting the role of combination therapy in improving treatment outcomes.
anti-inflammatory drugs (NSAIDs) are widely used to treat pain and
inflammation in patients with arthritis, but the vascular effects of some
NSAIDs have cast doubt on whether they can be used in patients at risk for
cardiovascular (CV) disease. At the American Heart Association’s Scientific
Sessions 2016 held recently in New Orleans, Louisiana, US, Professor Steven
Nissen of the Cleveland Clinic in Cleveland, Ohio, US, presented latest data
from the PRECISION (Prospective Randomized Evaluation of Celecoxib Integrated
Safety vs Ibuprofen or Naproxen) trial that evaluated the CV risk and safety
profile of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib vs